Correlation Between Esperion Therapeutics and Revvity

Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Revvity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Revvity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Esperion Therapeutics and Revvity, you can compare the effects of market volatilities on Esperion Therapeutics and Revvity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Revvity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Revvity.

Diversification Opportunities for Esperion Therapeutics and Revvity

-0.47

Correlation Coefficient

Esperion Therapeutics  Revvity

Very good diversification

The 3 months correlation between Esperion and Revvity is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Revvity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revvity and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Revvity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revvity has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Revvity go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and Revvity

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 2.77 times more return on investment than Revvity. However, Esperion Therapeutics is 2.77 times more volatile than Revvity. It trades about 0.14 of its potential returns per unit of risk. Revvity is currently generating about -0.04 per unit of risk. If you would invest  183.00  in Esperion Therapeutics on August 30, 2024 and sell it today you would earn a total of  71.00  from holding Esperion Therapeutics or generate 38.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Esperion Therapeutics  vs.  Revvity

Esperion Therapeutics

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Revvity

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Revvity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Revvity is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Esperion Therapeutics and Revvity

The main advantage of trading using opposite Esperion Therapeutics and Revvity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Revvity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revvity will offset losses from the drop in Revvity's long position.

The idea behind Esperion Therapeutics and Revvity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.